论文部分内容阅读
近年来,艾滋病感染人数急剧增加,已成为威胁人类健康的重大疾病。为了对抗HIV药物的研究现状和发展趋势进行深入分析,本文通过在Derwent Innovations Index数据库中检索2006-2012年的抗HIV药物专利。对采集的专利信息用TDA软件进行数据清洗,利用专利计量分析方法,借助可视化的分析工具,从专利申请数量、优先权国、专利技术机构和专利技术领域等方面进行分析。研究发现近几年抗HIV药物专利申请数量较为平稳;专利申请主要集中在美国、加拿大和中国;抗HIV药物的技术领域主要集中在天然产物、发酵工业和杂环化合物等方面。美国在专利申请数量方面远远领先于其他国家,足以见美国在抗HIV药物研发的活跃和强劲的技术实力。我国虽然在专利申请数量方面具有一定优势,但是与国外相比仍有较大差距。
In recent years, the number of HIV infections has risen sharply and has become a serious disease that threatens human health. In order to further analyze the research status and development trend of HIV drugs, this paper searches the Derwent Innovations Index database for anti-HIV drug patents from 2006 to 2012. The patent information collected by TDA software for data cleaning, the use of patented econometric analysis method, with the help of visual analysis tools, from the number of patent applications, priority countries, patented technology institutions and areas of patent technology and other aspects of analysis. The study found that in recent years, the number of anti-HIV drug patent applications has been relatively steady; patent applications are mainly concentrated in the United States, Canada and China; the technical fields of anti-HIV drugs are mainly concentrated in natural products, fermentation industry and heterocyclic compounds. The United States is far ahead of other countries in the number of patent applications. It is enough to see the United States’ active and strong technological strength in anti-HIV drug development. Although our country has certain advantages in the number of patent applications, there is still a long way to go compared with foreign countries.